WEHI-164 CLONE 2F - INVITRO ANTITUMOR EFFECTS OF TUMOR-NECROSIS-FACTOR AND GAMMA-INTERFERON

被引:0
|
作者
LATTIME, EC
STUTMAN, O
机构
关键词
TUMOR NECROSIS FACTOR; GAMMA-INTERFERON; WEHI-164; CLONE; 2F;
D O I
暂无
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Based on their enhanced susceptibility to tumor necrosis factor (TNF), sublines of the BALB/c fibrosarcoma WEHI-164 are more and more frequently being used to measure levels of TNF in cell-free supernatants. In studies aimed at characterizing the cytostatic and cytolytic effects of TNF and gamma-interferon (IFN-gamma) on a highly TNF-sensitive subline of WEHI-164, we show that: (1) the MTT assay which measures viable cell numbers (i.e. both cytostasis and cytolysis) at appropriate target cell numbers is sensitive to less than 0.1 pg/ml of recombinant murine TNF (rmTNF) without the need to add protein synthesis inhibitors such as actinomycin D; (2) using irradiated cells. the MTT assay is significantly more sensitive and measures cell lysis but not stasis; (3) clone 2F is sensitive to the cytostatic, but not cytolytic effects of recombinant murine IFN-gamma; (4) although lysis of 2F by rmTNF requires more than 5 h, a short exposure (30-60 min) to rmTNF is sufficient to trigger the lytic process, and (5) lysis of 2F is not cell-cycle-dependent. The use of highly sensitive indicator cell lines such as 2F allow for the measurement of low levels of TNF present in culture supernatants and for studies into the mechanism of action of TNF. However, sensitivity to other agents such as IFN supports the need to confirm that the antitumor effects seen are due to TNF via neutralizing antibody.
引用
收藏
页码:34 / 45
页数:12
相关论文
共 50 条
  • [1] WEHI-13VAR - A STABLE AND SENSITIVE VARIANT OF WEHI-164 CLONE-13 FIBROSARCOMA FOR TUMOR-NECROSIS-FACTOR BIOASSAY
    KHABAR, KSA
    SIDDIQUI, S
    ARMSTRONG, JA
    IMMUNOLOGY LETTERS, 1995, 46 (1-2) : 107 - 110
  • [2] A HIGHLY SENSITIVE CELL-LINE, WEHI-164 CLONE 13, FOR MEASURING CYTOTOXIC FACTOR TUMOR-NECROSIS-FACTOR FROM HUMAN-MONOCYTES
    ESPEVIK, T
    NISSENMEYER, J
    JOURNAL OF IMMUNOLOGICAL METHODS, 1986, 95 (01) : 99 - 105
  • [3] CLINICAL AND BIOLOGIC EFFECTS OF COMBINATION THERAPY WITH GAMMA-INTERFERON AND TUMOR-NECROSIS-FACTOR
    SCHILLER, JH
    WITT, PL
    STORER, B
    ALBERTI, D
    TOMBES, MB
    ARZOOMANIAN, R
    BROWN, RR
    PROCTOR, RA
    VOSS, SD
    SPRIGGS, DR
    TRUMP, DL
    BORDEN, EC
    CANCER, 1992, 69 (02) : 562 - 571
  • [4] SYNERGISTIC ANTITUMOR EFFECTS OF TUMOR-NECROSIS-FACTOR AND GAMMA-INTERFERON ON HUMAN-COLON CARCINOMA CELL-LINES
    SCHILLER, JH
    BITTNER, G
    STORER, B
    WILLSON, JKV
    CANCER RESEARCH, 1987, 47 (11) : 2809 - 2813
  • [6] EFFECT OF RECOMBINANT TUMOR-NECROSIS-FACTOR ON TUMORICIDAL ACTIVATION OF MURINE MACROPHAGES - SYNERGISM BETWEEN TUMOR-NECROSIS-FACTOR AND GAMMA-INTERFERON
    HORI, K
    EHRKE, MJ
    MACE, K
    MIHICH, E
    CANCER RESEARCH, 1987, 47 (22) : 5868 - 5874
  • [7] CYTOTOXIC EFFECTS OF TUMOR-NECROSIS-FACTOR AND GAMMA-INTERFERON ON ACUTE MYELOID-LEUKEMIA BLASTS
    PRICE, G
    BRENNER, MK
    PRENTICE, HG
    HOFFBRAND, AV
    NEWLAND, AC
    BRITISH JOURNAL OF CANCER, 1987, 55 (03) : 287 - 290
  • [8] THE SYNERGISM OF GAMMA-INTERFERON AND TUMOR-NECROSIS-FACTOR IN WHOLE-BODY HYPERTHERMIA
    ROSEN, P
    MEDICAL HYPOTHESES, 1990, 33 (03) : 173 - 174
  • [9] INTRAPERITONEAL ADMINISTRATION OF THE BIOLOGIC AGENTS TUMOR-NECROSIS-FACTOR, GAMMA-INTERFERON AND INTERLEUKIN-2
    MARKMAN, M
    BEREK, JS
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 1992, 2 : 30 - 34
  • [10] CYTOTOXIC EFFECTS OF TUMOR-NECROSIS-FACTOR AND GAMMA-INTERFERON ON CULTURED HUMAN PANCREATIC-CARCINOMA CELLS
    RAITANO, AB
    SCUDERI, P
    KORC, M
    CLINICAL RESEARCH, 1987, 35 (01): : A127 - A127